SCHEMBL17037848

SCHEMBL17037848

CC(C)(C)OC(=O)N1C2CCC1c1cc(I)ccc12

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GPR119 Q8TDV5 5/20 0.38
HSD11B1 P28845 1/20 0.38
KDM4E B2RXH2 2/20 0.36
PREP P48147 2/20 0.36
CNR1 P21554 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
PTPN2 P17706 1/20 0.35
PTPN1 P18031 1/20 0.35
PTPN6 P29350 1/20 0.35
BCHE P06276 1/20 0.35
ALDH1A1 P00352 1/20 0.34
ABCB1 P08183 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29865853 0.83 CNR1 (0.46) CHRM2CHRM1CHRM3GPR119HSD11B1
SCHEMBL30040501 0.83 CNR1 (0.46) CHRM2CHRM1CHRM3GPR119HSD11B1
SCHEMBL13138460 0.83 NR1H2 (0.46) CHRM2CHRM1CHRM3GPR119HSD11B1
SCHEMBL30040477 0.82 ALDH1A1 (0.46) CHRM2CHRM1CHRM3GPR119ALDH1A1
SCHEMBL30039889 0.82 ALDH1A1 (0.46) CHRM2CHRM1CHRM3GPR119ALDH1A1
SCHEMBL13137753 0.82 GPR119 (0.47) CHRM2CHRM1CHRM3GPR119HSD11B1
SCHEMBL14428711 0.81 GPR119 (0.42) CHRM2CHRM1CHRM3GPR119HSD11B1
SCHEMBL29697662 0.81 GPR119 (0.42) CHRM2CHRM1CHRM3GPR119HSD11B1
SCHEMBL14428713 0.81 CHRM2 (0.38) CHRM2CHRM1CHRM3GPR119HSD11B1
Hydrochloric Acid SCHEMBL30041068 0.81 GPR119 (0.46) CHRM2CHRM1CHRM3GPR119HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170152239-A1 BENZAMIDE AND HETEROBENZAMIDE COMPOUNDS PFIZER INC. (US) 2017-06-01 US disclosed
US-20170152239-A1 BENZAMIDE AND HETEROBENZAMIDE COMPOUNDS PFIZER INC. (US) 2017-06-01 US disclosed
US-20150239842-A1 BENZAMIDE AND HETEROBENZAMIDE COMPOUNDS PFIZER INC. (US) 2015-08-27 US disclosed
US-20150239842-A1 BENZAMIDE AND HETEROBENZAMIDE COMPOUNDS PFIZER INC. (US) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239842-A1 BENZAMIDE AND HETEROBENZAMIDE COMPOUNDS HRH2, H1-0, H1-2 CHRM2 142/4885CHRM1 253/4885CHRM3 645/4885
US-20170152239-A1 BENZAMIDE AND HETEROBENZAMIDE COMPOUNDS HRH2, HRH4, H1-0 CHRM2 173/4885CHRM1 355/4885CHRM3 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.